Hydrocortison 1% Smartpractice Europe (Hydrocortisone)

Hydrocortison 1% Smartpractice Europe is indicated for a range of mild to moderate inflammatory skin conditions where a low‑potency corticosteroid is appropriate.

• Relief of mild eczema and atopic dermatitis flare‑ups.
• Treatment of contact dermatitis caused by irritants or allergens.
• Management of mild psoriasis plaques.
• Soothing of insect bite reactions and localized itching.
• Adjunctive care for minor burns or superficial skin abrasions.

• Hydrocortison 1% delivers hydrocortisone to the epidermis, where it binds to intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus and modulates gene transcription, resulting in decreased production of pro‑inflammatory cytokines, prostaglandins, and leukotrienes. This down‑regulation of inflammatory mediators reduces vasodilation, edema, and immune cell infiltration, providing anti‑inflammatory and immunosuppressive effects at the site of application.

Topical hydrocortisone may cause local skin reactions; systemic effects are uncommon when used as directed.

Common

• Mild burning or stinging sensation at the application site.
• Transient itching or dryness.
• Slight erythema or redness.
• Minor skin irritation or folliculitis.

Serious

• Signs of skin atrophy such as thinning or bruising.
• Development of contact dermatitis or allergic reaction.
• Secondary bacterial, fungal, or viral infection of the treated area.
• Systemic corticosteroid effects (e.g., adrenal suppression) with extensive or prolonged use.

When using Hydrocortison 1% Smartpractice Europe, follow these safety considerations to minimize risks and ensure appropriate use.

• Apply a thin layer only to the affected skin and avoid covering with occlusive dressings unless directed.
• Do not use on broken skin, open wounds, or mucous membranes.
• Limit use to the recommended duration, typically no longer than two weeks without medical review.
• Discontinue if signs of irritation, worsening rash, or allergic reaction develop.
• Consult a healthcare professional before use on children, pregnant or breastfeeding individuals, or extensive body surface areas.
• Avoid use on infected skin without prior treatment of the infection.

Hydrocortison 1% may interact with other topical or systemic agents; consider the following when co‑administering.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area.
• Application of topical calcineurin inhibitors (e.g., tacrolimus) without a washout period.
• Use with skin‑sensitizing chemicals such as harsh antiseptics or solvents.

Use with caution

• Systemic corticosteroids, as combined effects may increase systemic exposure.
• Antifungal or antibacterial creams that may alter skin barrier function.
• Phototherapy or UV exposure, which can increase risk of skin thinning.